Saturday, Apr 04th
Last update12:46:12 AM GMT
Drug companies are blocking or delaying the entry of cheaper generic medicines into the EU, pushing up medicine bills, the European Commission has said.
Their actions cost EU healthcare providers 3bn euros ($3.9bn; £2.5bn) in savings between 2000 and 2007, it said.
 More than 3.1 million bottles of eye drops sold at major retailers, including Walgreens and CVS,... |
 The abortion rate is holding steady in the US despite total and partial bans in some... | ||
 The Supreme Court sided with a Christian counselor on Tuesday in her free speech challenge to... |
 A new COVID-19 variant, BA.3.2, has been detected in 25 states, according to a recent report... |
